Multi-antibiotic Resistance
18
4
4
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
2 terminated out of 18 trials
80.0%
-6.5% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (18)
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
Resistant Bacteria in Children in France
Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
Perinatal Transmission of MDR Bacteria
Use of New Antibiotics in Sweden
Screening of Multidrug Resistant Bacteria, and the Clinical Implication for the Patient
Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO
Multi-drug Resistant Gram-negative Bacteria and Veno-venous Extracorporeal Membrane Oxygenation (ECMO)
Ventilator Associated Pneumonia by Multi-Drug Resistant Organism
Factors Impacting the Prevalence of MDR Bacteria
Fecal Transplant for MDRO Decolonization
Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs.
Can Environmental Cleanliness be Assessed by BCA (Bicinchoninic Acid) Method
Fecal Transplant for MDR Pathogen Decolonization
Use of Aaerosol Combined With Intravenous Antibiotics for the Treatment of Multidrug Resistant GNB Pneumonia
Pathway From Functional Disability to Antimicrobial Resistance in Nursing Home Residents
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis